- Home
- CGO vs ANIK Comparison
CGO vs ANIK Comparison
Compare CGO & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGO
- ANIK
- Stock Information
- Founded
- CGO 2004
- ANIK 1983
- Country
- CGO United States
- ANIK United States
- Employees
- CGO N/A
- ANIK N/A
- Industry
- CGO Investment Managers
- ANIK Medical/Dental Instruments
- Sector
- CGO Finance
- ANIK Health Care
- Exchange
- CGO Nasdaq
- ANIK Nasdaq
- Market Cap
- CGO 114.5M
- ANIK 133.1M
- IPO Year
- CGO N/A
- ANIK 1993
- Fundamental
- Price
- CGO $11.21
- ANIK $9.84
- Analyst Decision
- CGO
- ANIK Buy
- Analyst Count
- CGO 0
- ANIK 1
- Target Price
- CGO N/A
- ANIK $16.00
- AVG Volume (30 Days)
- CGO 34.7K
- ANIK 163.1K
- Earning Date
- CGO 01-01-0001
- ANIK 11-05-2025
- Dividend Yield
- CGO 9.25%
- ANIK N/A
- EPS Growth
- CGO N/A
- ANIK N/A
- EPS
- CGO N/A
- ANIK N/A
- Revenue
- CGO N/A
- ANIK $112,806,000.00
- Revenue This Year
- CGO N/A
- ANIK N/A
- Revenue Next Year
- CGO N/A
- ANIK $4.57
- P/E Ratio
- CGO N/A
- ANIK N/A
- Revenue Growth
- CGO N/A
- ANIK 30.55
- 52 Week Low
- CGO $7.90
- ANIK $7.87
- 52 Week High
- CGO $10.93
- ANIK $18.37
- Technical
- Relative Strength Index (RSI)
- CGO 36.07
- ANIK 51.07
- Support Level
- CGO $10.87
- ANIK $9.22
- Resistance Level
- CGO $11.28
- ANIK $10.17
- Average True Range (ATR)
- CGO 0.20
- ANIK 0.38
- MACD
- CGO -0.04
- ANIK -0.02
- Stochastic Oscillator
- CGO 29.90
- ANIK 51.16
About CGO Calamos Global Total Return Fund
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.